OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,632 | -77.6% | 1,475 | -63.2% | 0.00% | – |
| Q2 2023 | $20,661 | -20.8% | 4,012 | -19.1% | 0.00% | – |
| Q1 2023 | $26,084 | +86.3% | 4,957 | +4.9% | 0.00% | – |
| Q4 2022 | $14,000 | -30.0% | 4,725 | -2.1% | 0.00% | – |
| Q3 2022 | $20,000 | +33.3% | 4,825 | +29.5% | 0.00% | – |
| Q2 2022 | $15,000 | -16.7% | 3,725 | 0.0% | 0.00% | – |
| Q1 2022 | $18,000 | -82.9% | 3,725 | -75.3% | 0.00% | – |
| Q4 2021 | $105,000 | +128.3% | 15,076 | +229.5% | 0.00% | – |
| Q3 2021 | $46,000 | -4.2% | 4,576 | +35.5% | 0.00% | – |
| Q2 2021 | $48,000 | +17.1% | 3,376 | +35.0% | 0.00% | – |
| Q1 2021 | $41,000 | +241.7% | 2,501 | +316.1% | 0.00% | – |
| Q4 2020 | $12,000 | +33.3% | 601 | -47.7% | 0.00% | – |
| Q3 2020 | $9,000 | +28.6% | 1,150 | +27.8% | 0.00% | – |
| Q2 2020 | $7,000 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,804,788 | $15,105,000 | 43.34% |
| Versant Venture Management, LLC | 2,215,384 | $8,795,074,000 | 2.90% |
| Opaleye Management Inc. | 1,900,000 | $7,543,000 | 2.09% |
| SV Health Investors, LLC | 628,236 | $2,494,000 | 1.46% |
| Endurant Capital Management LP | 716,124 | $2,843,000 | 1.12% |
| DELTEC ASSET MANAGEMENT LLC | 824,747 | $3,274,000 | 0.72% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $583,000 | 0.08% |
| Jump Trading, LLC | 39,255 | $156,000 | 0.05% |
| Man Group plc | 1,723,456 | $6,842,000 | 0.03% |
| JGP Global Gestao de Recursos Ltda. | 13,880 | $55,000 | 0.02% |